Serving hundreds of leading biopharmaceutical companies globally:

Generated: September 23, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,367,102

Try a free trial

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 8,367,102 protect, and when does it expire?

Patent 8,367,102 protects ABSORICA and is included in one NDA.

This patent has twelve patent family members in nine countries.

Summary for Patent: 8,367,102

Title:	Pharmaceutical semi-solid composition of isotretinoin
Abstract:	An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e. having an HLB value superior or equal to 10), the other being an oily vehicle.
Inventor(s):	Vanderbist; Francis (Beersel, BE), Servais; Cecile (Malonne, BE), Baudier; Phillippe (Uccle, BE)
Assignee:	Galephar Pharmaceutical Research, Inc. (Juncos, PR)
Application Number:	11/892,363
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,367,102
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Dosage form;

Drugs Protected by US Patent 8,367,102

Subscribe to access the full database, or request a copy of the full page.
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Sun Pharm Inds Inc	ABSORICA	isotretinoin	CAPSULE;ORAL	021951-001	May 25, 2012	BX	RX	Yes	No	➤ Sign Up	➤ Sign Up				TREATMENT OF A SKIN DISORDER	➤ Sign Up
Sun Pharm Inds Inc	ABSORICA	isotretinoin	CAPSULE;ORAL	021951-002	May 25, 2012	BX	RX	Yes	No	➤ Sign Up	➤ Sign Up				TREATMENT OF A SKIN DISORDER	➤ Sign Up
Sun Pharm Inds Inc	ABSORICA	isotretinoin	CAPSULE;ORAL	021951-005	Aug 15, 2014		RX	Yes	No	➤ Sign Up	➤ Sign Up				TREATMENT OF A SKIN DISORDER	➤ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 8,367,102

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Belgium	2000/0111	Sep 22, 2000

International Family Members for US Patent 8,367,102

Subscribe to access the full database, or request a copy of the full page.
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	270544	➤ Sign Up
Australia	8943801	➤ Sign Up
Brazil	102013032172	➤ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.